Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. Read more about Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial. Read more about Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial.
An inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer. Read more about An inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer.
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. Read more about High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks. Read more about Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks.
Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. Read more about Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms.
A generalisation of the method of regression calibration. Read more about A generalisation of the method of regression calibration.
Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. Read more about Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression. Read more about Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression.
A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion. Read more about A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion.
